Pnc Financial Services Group, Inc. Cassava Sciences Inc Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Cassava Sciences Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 2,318 shares of SAVA stock, worth $4,751. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,318
Previous 116
1898.28%
Holding current value
$4,751
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding SAVA
# of Institutions
155Shares Held
15.7MCall Options Held
1.67MPut Options Held
1.26M-
Black Rock Inc. New York, NY3.22MShares$6.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.44MShares$5.01 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.03MShares$2.1 Million0.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny909KShares$1.86 Million0.0% of portfolio
-
State Street Corp Boston, MA874KShares$1.79 Million0.0% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $82.2M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...